Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) — Analysis Summary
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) has a market cap of $11.46B with year-over-year revenue growth of +432.1%. Net margin stands at -30.1%. The stock trades at a P/E ratio of -37.1.
Key Takeaways
- Revenue changed +432.1% year-over-year
- Net margin of -30.1%
- P/E ratio of -37.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, MDGL posted revenue growth of +432.1% and trades at a P/E of -37.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.